Table 6.
Long-term |
CD38+IgD- (Bm5) |
CD38+IgD+ (Mature Bm2) |
CD38++IgD- (Immature/T1) |
CD38++IgD+ (Immature/T1) |
CD38+++IgD- (Plasma blasts) |
RTX-naïve n = 24 |
75 ± 54 | 205 ± 139 | 171 ± 258 | 39 ± 51 | 35 ± 26 |
RTX-treated n = 13 |
17 ± 19 P = 0.0004 |
155 ± 134 P = ns |
222 ± 292 P = ns |
19 ± 15 P = ns |
22 ± 18 P = ns |
* Values are given as mean ± standard deviation.
** Statistics are calculated with paired T-test, P-values are given in comparison to day 0.
RTX = rituximab.